RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
A mesenchymal neoplasm most commonly seen in the gastrointestinal tract. Cases involving tissues outside the gastrointestinal tract have also been reported (extragastrointestinal gastrointestinal stromal tumor). It is a specific KIT-expressing and KIT-signaling-driven mesenchymal tumor. Until recently, surgery has been the only effective therapy for this tumor. However, many patients still experience recurrence. Conventional chemotherapy and radiation therapy have been of limited value. A KIT tyrosine kinase inhibitor, imatinib mesylate (also known as STI-571 or Gleevec), is now effective in the treatment of relapsed and unresectable cases. - 2003
View Complete Description Individual Studies |
|
|---|---|
|
|
Authors: Brian P Rubin, Michael C Heinrich, Christopher L Corless
Lancet 2007 May 19Authors: Ronald P Dematteo, Karla V Ballman, Cristina R Antonescu, Robert G Maki, Peter W T Pisters, George D Demetri, Martin E Blackstein, Charles D Blanke, Margaret von Mehren, Murray F Brennan,…
Lancet 2009 Mar 28Thought leaders and organizations working on research involving gastrointestinal stromal tumour.
conditions: Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors
interventions: Sunitinib Malate (SU011248)
conditions: Gastrointestinal Stromal Tumor
interventions: temozolomide
No NextBio users were found for “gastrointestinal stromal tumour”.
Complete
your user profile with your interests, if you want others to find you within the NextBio community.
No NextBio groups were found for “gastrointestinal stromal tumour”.
Be the first to
start
a group and share your interests with others within the NextBio community.